Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Franke

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and exploring potential pathways: A multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
BMJ Open Respiratory Research|December 25, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
Scientific Reports|January 23, 2026
Multicohort assessment of plasma metabolic signatures of tuberculosis disease in children: a retrospective cross-sectional studyMary M Nellis, Juaneta Luiz, Devan Jaganath, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 20, 2016
Travel-associated and autochthonous Zika virus infection in mainland France, 1 January to 15 July 2016A Septfons, I Leparc-Goffart, E Couturier, et al.
IJTLD Open|March 18, 2026
Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TBE Herrera-Flores, E Shen, D Vargas-Vasquez, et al.
Plos One|February 22, 2020
Outcomes of a primary care mental health implementation program in rural Rwanda: A quasi-experimental implementation-effectiveness studyStephanie L Smith, Molly F Franke, Christian Rusangwa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant TuberculosisKwonjune J Seung, Palwasha Khan, Molly F Franke, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatmentMatthew L Romo, Allison LaHood, Carole D Mitnick, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2020
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry StudyMolly F Franke, Palwasha Khan, Cathy Hewison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2023
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TBC Zeng, C D Mitnick, C Hewison, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and exploring potential pathways: A multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
BMJ Open Respiratory Research|December 25, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
Scientific Reports|January 23, 2026
Multicohort assessment of plasma metabolic signatures of tuberculosis disease in children: a retrospective cross-sectional studyMary M Nellis, Juaneta Luiz, Devan Jaganath, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 20, 2016
Travel-associated and autochthonous Zika virus infection in mainland France, 1 January to 15 July 2016A Septfons, I Leparc-Goffart, E Couturier, et al.
IJTLD Open|March 18, 2026
Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TBE Herrera-Flores, E Shen, D Vargas-Vasquez, et al.
Plos One|February 22, 2020
Outcomes of a primary care mental health implementation program in rural Rwanda: A quasi-experimental implementation-effectiveness studyStephanie L Smith, Molly F Franke, Christian Rusangwa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant TuberculosisKwonjune J Seung, Palwasha Khan, Molly F Franke, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatmentMatthew L Romo, Allison LaHood, Carole D Mitnick, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2020
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry StudyMolly F Franke, Palwasha Khan, Cathy Hewison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2023
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TBC Zeng, C D Mitnick, C Hewison, et al.
Pageof 26